Cargando…

Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2–5 and MAXIMISE studies

OBJECTIVES: Patients with psoriatic arthritis (PsA) are at a significantly increased risk of hyperuricaemia and development of gout, and those with hyperuricaemia have been found to respond poorly to PsA treatment and have more peripheral and destructive joint damage. We present a comprehensive post...

Descripción completa

Detalles Bibliográficos
Autores principales: Felten, Renaud, Widawski, Laura, Spielmann, Lionel, Gaillez, Corine, Bao, Weibin, Gottenberg, Jacques-Eric, Duret, Pierre-Marie, Messer, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649802/
https://www.ncbi.nlm.nih.gov/pubmed/37945285
http://dx.doi.org/10.1136/rmdopen-2023-003428